Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
All-case surveillance of Opdivo in relapsed or refractory classical Hodgkin's lymphoma
jRCT1080224013Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of nivolumab in classical Hodgkin lymphoma (cHL), sponsored by Ono Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on jRCT1080224013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224013.